Cash from Operations (Annual) Chart

Historical Cash from Operations (Annual) Data

View and export this data back to 2016. Start Trial.
Date Value
December 31, 2025 -46.36M
December 31, 2024 -104.50M
December 31, 2023 -105.36M
December 31, 2022 -73.10M
December 31, 2021 -10.53M
Date Value
December 31, 2020 -63.97M
December 31, 2019 20.04M
December 31, 2018 -58.89M
December 31, 2017 -18.06M
December 31, 2016 -14.37M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Xencor, Inc. -135.12M
UroGen Pharma Ltd. -162.44M
Ironwood Pharmaceuticals, Inc. 127.04M
Viking Therapeutics, Inc. -278.68M
IDEAYA Biosciences, Inc. -71.10M